Trademark Overview
On Wednesday, April 9, 2025, a trademark application was filed for BESREMI with the United States Patent and Trademark Office. The USPTO has given the BESREMI trademark a serial number of 99128870. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 9, 2025. This trademark is owned by PHARMAESSENTIA CORPORATION. The BESREMI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations; antineoplastic and immunomodulating agents; pharmaceutical preparations containing ropeginterferon alfa-2b for the treatment of viral infections, cancers, or Essential thrombocythemia (ET); medicines for human purposes for treating viral infections, cancers, or ET; chemical-pharmaceutical preparations containing ropeginterferon alfa-2b for treating viral infections, cancers, or ET.